On September 3, 2014, plaintiffs James J. Brien and Dolly S. Brien filed a new Xarelto lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Pharma AG. The case was filed in the U.S. District Court for the Eastern District of Louisiana. The plaintiffs claimed that after…
On July 29, 2014, Texas resident Jeanne Jeffcoat filed a new Xarelto lawsuit against manufacturer Janssen Pharmaceuticals and parent company Johnson & Johnson, and Bayer Healthcare AG. The case is currently pending in the U.S. District Court for the Eastern District of New York. According…
On November 2, 2012, the FDA approved the use of Xarelto (rivaroxaban) for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism, and to help patients reduce the risk of recurrence of these conditions. Illinois plaintiff Mary Lemp took the medication to prevent these…
On August 19, 2012, Illinois resident Jamie Rae filed a lawsuit against James Dalla Riva, an obstetrician who worked at Anderson Hospital in Maryville. Rae claimed that the doctor had failed to provide the right standard of care during the birth of her baby, resulting…
On June 23, 2014, Florida resident Nancy Packard filed a Xarelto wrongful death lawsuit on behalf of her husband, William N. Packard, Jr. She named as defendants the manufacturers of the anticoagulant drug, Johnson & Johnson (J&J) and Bayer AG. The case is currently pending…
On July 31, 2014, California resident Gonzalo Menendez filed a new testosterone lawsuit against Pfizer, Inc. The case is currently pending in the U.S. District Court for the Central District of California. According to court documents, the plaintiff used Depo-Testosterone as prescribed, but suffered
In February 2014, Kentucky resident Virginia Stuntebeck filed a new Xarelto lawsuit against drug manufacturers Johnson & Johnson (J&J) and Bayer AG. The case is pending in the Pennsylvania Court of Common Pleas. The plaintiff claims that after taking the anticoagulant, she suffered serious injuries…
Wet weather didn’t stop Chaffin Luhana employees from giving back to their local veterans on Thursday, November 6, 2014. Chaffin Luhana and the Chaffin Luhana Foundation were part of Injury Board’s first-ever “Day of Action.” This year, IB called on law firm members to give…
On September 17, 2014, the FDA convened an advisory panel meeting to review the safety and efficacy of testosterone replacement products like AndroGel and Testim. The panel, according to the New York Times and other media outlets, made some key recommendations as a result of…
The Institute for Safe Medicine Practices (ISMP) released its latest QuarterWatch report on May 7, 2014. In it, they revealed that the number of serious adverse event reports associated with Xarelto (rivaroxaban) now outnumber those from rival blood-thinning drug, Pradaxa (dabigatran). The ISMP adde
The Injury Board is encouraging its members to come together for its first-ever Day of Action and Chaffin Luhana is participating to help local veterans in both New York and the Ohio Valley. The “IB Day of Action” is a “nationwide community outreach” set for…
On August 29, 2014, Shirley and James Boynton filed a new Xarelto lawsuit against manufacturers Janssen Pharmaceuticals; parent company, Johnson and Johnson (J&J); and Bayer Healthcare Pharmaceuticals. The lawsuit is pending in the U.S. District Court for the Eastern District of New York. According